Acino Pharmaceuticals FZ Llc Pharmaceutical Import Profile — United Arab Emirates (DGFT 2022–2026)

Name: Acino Pharmaceuticals FZ Llc Pharmaceutical Import Records from India — 2 Products, $2.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Acino Pharmaceuticals FZ Llc — Pharmaceutical Importer Profile (2026) | 2 Products, $2.5M Trade | TransData Nexus

Acino Pharmaceuticals FZ Llc

Pharmaceutical Importer · United Arab Emirates · Respiratory Focus · $2.5M Total Trade · DGFT Verified

Acino Pharmaceuticals FZ Llc is a pharmaceutical importer based in United Arab Emirates with a total trade value of $2.5M across 2 products in 1 therapeutic categories. Based on 49 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Acino Pharmaceuticals FZ Llc sources from 5 verified Indian suppliers, with Cipla Limited accounting for 91.6% of imports.

Acino Pharmaceuticals FZ Llc — Import Portfolio & Supplier Network

Acino Pharmaceuticals FZ Llc import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Acino Pharmaceuticals FZ Llc?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Cipla Limited	$2.7M	129	91.6%
Jubilant Generics Limited	$127.1K	3	4.4%
Recipharm Pharmaservices Private Limited

What Formulations Does Acino Pharmaceuticals FZ Llc Import?

Formulation	Value	Ships
Budecort 0.25MG/ML respules (budesonideinhalation suspension 0.25MG/ML) [pac size:12x5x2 mlx3648 pac=218880	$283.8K	6
Budecort 0.25MG/ML respules (budesonideinhalation suspension 0.25MG/ML) [pac size:12x5x2 mlx3682 pac=220920	$142.3K	3
Budecort 0.25MG/ML respules (budesonideinhalation suspension 0.25MG/ML) (qty: 3648 pac) (Pack size: 12 x 5 x 2 ML	$142.1K	3
Budecort 0.25MG/ML respules (budesonideinhalation suspension 0.25MG/ML) (12 x 5 x3624 Pack = 217440 nos) (2 ML	$141.8K	3
Budecort 0.25MG/ML respules (budesonideinhalation suspension 0.25MG/ML) (qty: 3572 pac) (Pack size: 12 x 5 x 2 ML	$141.2K	3
Budecort 0.25MG/ML respules (budesonideinhalation suspension 0.25MG/ML)(3552 packs x 12x5 = 213120 nos)(2ML	$137.5K	3
Urimax 0.4MG capsules [pac size:6x10x9325 pac=559500	$129.6K	3
Seroflo 250 MCG inhaler (salmeterol xinafoate 25mcg+fluticasone propionate 250 MCG	$100.0K	2
Budecort 0.25MG/ML respules (budesonide inhalation suspension 0.25MG/ML) (inv.qty. 3593 Pack 12x5x2	$100.0K	2
Budecort 0.25MG/ML respules (budesonide inhalation suspension 0.25MG/ML) (inv.qty. 3600 Pack 12x5x2	$100.0K	2
Budecort 0.25MG/ML respules (budesonide inhalation suspension 0.25MG/ML) (inv qty.3511 packx12x5x2	$100.0K	2
Budecort 0.25MG/ML respules (budesonide inhalation suspension 0.25MG/ML) (inv qty.3552 packx12x5x2	$100.0K	2
Budecort 0.5MG/ML respules (budesonide inhalation suspension 1MG/2ML) [pac size:12x5x2 mlx3000 pac=180000	$90.6K	3
Budecort 0.5MG/ML respules budesonide inhalation suspension 1MG/2ml3024 packsx12x5 =1814402ML	$50.0K	1
Budecort 0.5MG/ML respules budesonide inhalation suspension 1MG/2ml3048 packsx12x5 =1828802ML	$50.0K	1

Acino Pharmaceuticals FZ Llc imports 96 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Budesonide	Respiratory	$2.4M	47	1.2%	2
2	Formoterol	Respiratory	$100.0K	2	0.2%	15

Acino Pharmaceuticals FZ Llc imports 2 pharmaceutical products across 1 categories into United Arab Emirates totaling $2.5M.

Acino Pharmaceuticals FZ Llc — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Acino Pharmaceuticals FZ LLC is a pharmaceutical importer and distributor based in Dubai, United Arab Emirates (UAE). The company specializes in sourcing and distributing finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Acino Pharmaceuticals FZ LLC operates as a subsidiary of Acino International AG, a Swiss pharmaceutical company established in 1836, renowned for its focus on emerging markets in the Middle East, Africa, the CIS region, and Latin America. The UAE subsidiary plays a pivotal role in Acino's strategy to enhance access to quality healthcare in the Middle East by ensuring the availability of essential medications.

2Distribution Network

Acino Pharmaceuticals FZ LLC maintains a robust distribution network within the UAE, with its primary operations centered in Dubai. The company leverages Dubai's strategic location and advanced logistics infrastructure to facilitate efficient importation and distribution of pharmaceutical products. While specific warehouse locations are not publicly disclosed, the company's operations are designed to ensure timely delivery of medical products across the UAE and potentially to neighboring regions. This logistical capability underscores Acino's commitment to meeting the healthcare needs of the Middle East.

3Industry Role

In the UAE's pharmaceutical supply chain, Acino Pharmaceuticals FZ LLC functions as a primary wholesaler and distributor. The company imports finished pharmaceutical formulations from various suppliers, predominantly from India, and distributes these products to healthcare facilities, pharmacies, and other stakeholders within the UAE. By focusing on the importation and distribution of finished dosage forms, Acino Pharmaceuticals FZ LLC ensures a steady supply of essential medications, thereby contributing significantly to the healthcare infrastructure of the region.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Acino Pharmaceuticals FZ Llc

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Acino Pharmaceuticals FZ LLC exhibits a high degree of sourcing concentration, with a substantial majority of its pharmaceutical imports originating from India. Between 2022 and 2026, the company imported finished pharmaceutical formulations valued at $2.5 million USD, with 49 shipments. The top five products imported were Budesonide ($2.4 million, Rank #2, 1.2% share) and Formoterol ($100,000, Rank #15, 0.2% share), both sourced from Indian suppliers. This concentration indicates a strategic choice to leverage India's established pharmaceutical manufacturing capabilities, ensuring access to a diverse range of high-quality products.

The primary supplier, Cipla Limited, accounted for 91.6% of the total import value, suggesting a strong and stable relationship. The remaining suppliers, including Jubilant Generics Limited, Recipharm Pharmaservices Private Limited, Ind-Swift Limited, and Aurobindo Pharma Limited, contributed smaller shares, indicating a diversified yet concentrated supplier base. This sourcing strategy may offer cost advantages and supply chain stability but also presents risks associated with over-reliance on a limited number of suppliers.

2Supply Chain Resilience

Acino Pharmaceuticals FZ LLC's supply chain resilience is bolstered by its diversified supplier base, despite the concentration in sourcing from India. The company imports a total of 96 unique formulations, indicating a broad product portfolio that can mitigate risks associated with individual product shortages. The presence of multiple suppliers, such as Cipla Limited, Jubilant Generics Limited, Recipharm Pharmaservices Private Limited, Ind-Swift Limited, and Aurobindo Pharma Limited, provides alternative sourcing options, enhancing the company's ability to adapt to supply chain disruptions. However, the heavy reliance on a single country for sourcing may expose the company to geopolitical and logistical challenges. To further strengthen resilience, Acino Pharmaceuticals FZ LLC could consider expanding its supplier base to include manufacturers from other countries, thereby reducing dependency on a single region.

Importing Pharmaceuticals into United Arab Emirates — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United Arab Emirates

1Regulatory Authority & Framework

The UAE's pharmaceutical sector is regulated by the Emirates Drug Control Department (EDE), which operates under the Ministry of Health and Prevention. The EDE is responsible for overseeing the import, export, and distribution of medical products, ensuring compliance with safety, quality, and efficacy standards. Key legislation governing pharmaceutical imports includes the Federal Decree-Law No. (8) of 2019 on Medical Products, Pharmacy Profession, and Pharmaceutical Facilities, which outlines the regulatory framework for medical products in the UAE. Additionally, the Cabinet Resolution Concerning the Executive Regulations of Federal Law No. (8) of 2019 provides detailed guidelines on the importation and distribution of medical products. (uaelegislation.gov.ae)

2Import Licensing & GMP

Import licensing in the UAE requires obtaining approval from the EDE for each shipment of medical products. This process ensures that imported products meet the necessary safety and quality standards. The EDE may cancel approvals or permits if it is proven that they were obtained through fraudulent means or if new data indicates that the medical product is unsafe. Regarding Good Manufacturing Practice (GMP), the UAE recognizes certifications from reputable international bodies, including the European Union (EU) GMP, World Health Organization (WHO) GMP, and Pharmaceutical Inspection Co-operation Scheme (PIC/S). Importers must ensure that their suppliers hold valid GMP certifications to comply with UAE regulations. (uaelegislation.gov.ae)

Acino Pharmaceuticals FZ Llc — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Acino Pharmaceuticals FZ LLC's focus on importing respiratory medications, particularly Budesonide and Formoterol, aligns with the growing demand for respiratory treatments in the UAE. The prevalence of respiratory conditions, such as asthma and chronic obstructive pulmonary disease (COPD), has been rising, necessitating a steady supply of effective medications. By concentrating on this therapeutic area, Acino Pharmaceuticals FZ LLC addresses a critical healthcare need, ensuring that patients have access to essential respiratory treatments. This strategic focus not only meets market demand but also positions the company as a key player in the respiratory pharmaceutical segment within the UAE.

2Sourcing Profile

Acino Pharmaceuticals FZ LLC's sourcing strategy emphasizes the importation of generic drugs, primarily from India, to offer cost-effective and high-quality pharmaceutical products. The company's preference for finished formulations, such as tablets and inhalers, reflects a strategic decision to provide ready-to-use medications that meet the therapeutic needs of the UAE market. India's robust pharmaceutical manufacturing sector, with its adherence to international quality standards, makes it a reliable source for these products. This sourcing approach enables Acino Pharmaceuticals FZ LLC to maintain a diverse product portfolio while ensuring affordability and accessibility for patients.

Market Positioning

Seller's Guide — How to Become a Supplier to Acino Pharmaceuticals FZ Llc

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Acino Pharmaceuticals FZ LLC, especially in the respiratory therapeutic category, where the company has demonstrated substantial import activity. By aligning with Acino's product focus and quality standards, Indian exporters can enhance their market presence in the UAE and potentially in other Middle Eastern markets.

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Acino Pharmaceuticals FZ Llc

What products does Acino Pharmaceuticals FZ Llc import from India?

Acino Pharmaceuticals FZ Llc imports 2 pharmaceutical products across 1 categories. Top imports: Budesonide ($2.4M), Formoterol ($100.0K).

Who supplies pharmaceuticals to Acino Pharmaceuticals FZ Llc from India?

Acino Pharmaceuticals FZ Llc sources from 5 verified Indian suppliers. The primary supplier is Cipla Limited (91.6% of imports, $2.7M).

What is Acino Pharmaceuticals FZ Llc's total pharmaceutical import value?

Acino Pharmaceuticals FZ Llc's total pharmaceutical import value from India is $2.5M, based on 49 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Acino Pharmaceuticals FZ Llc focus on?

Acino Pharmaceuticals FZ Llc imports across 1 categories. The largest: Respiratory (100.0%).

Get Full Acino Pharmaceuticals FZ Llc Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.